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Abstract
Brachycephalic obstructive airway syndrome (BOAS) is an important health and welfare
problem in several popular dog breeds. Whole-body barometric plethysmography (WBBP)
is a non-invasive method that allows safe and repeated quantitative measurements of respi-
ratory cycles on unsedated dogs. Here respiratory flow traces in French bulldogs from the
pet population were characterised usingWBBP, and a computational application was devel-
oped to recognise affected animals. Eighty-nine French bulldogs and twenty non-brachyce-
phalic controls underwent WBBP testing. A respiratory functional grading system was used
on each dog based on respiratory signs (i.e. respiratory noise, effort, etc.) before and after
exercise. For development of an objective BOAS classifier, functional Grades 0 and I were
considered to have insignificant clinical signs (termed here BOAS-) and Grades II and III to
have significant signs (termed here BOAS+). A comparison between owner-perception of
BOAS and functional grading revealed that 60 % of owners failed to recognise BOAS in
dogs that graded BOAS+ in this study.WBBP flow traces were found to be significantly differ-
ent between non-brachycephalic controls and Grade 0 French bulldogs; BOAS- and BOAS+
French bulldogs. A classifier was developed using quadratic discriminant analysis of the
respiratory parameters to distinguish BOAS- and BOAS + French bulldogs, and a BOAS
Index was calculated for each dog. A cut-off value of the BOAS Index was selected based
on a receiver operating characteristic (ROC) curve. Sensitivity, specificity, positive predictive
value, and negative predictive value of the classifier on the training group (n=69) were 0.97,
0.93, 0.95, and 0.97, respectively. The classifier was validated using a test group of French
bulldogs (n=20) with an accuracy of 0.95. WBBP offers objective screening for the diagnosis
of BOAS in French Bulldogs. The technique may be applied to other brachycephalic breeds
affected by BOAS, and possibly to other respiratory disease in dogs.
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Introduction
Brachycephalic Obstructive Airway Syndrome (BOAS) is a common respiratory disorder in
brachycephalic (i.e. short-skulled, flat-faced) canine breeds such as pugs, French bulldogs (FB),
and bulldogs. Excessive breeding selection for brachycephaly has led to deformation in the
upper respiratory tract and subsequent airway obstructions because the soft tissues are not
reduced in the same proportion as the skull [1,2]. Primary lesions may include an oversized
soft palate, stenotic nares, redundant pharyngeal folds, deviated nasal septum, aberrant conchal
growth, hypertrophic tonsils, hypoplastic trachea, and macroglossia. Secondary lesions include
everted laryngeal saccules and laryngeal collapse. BOAS-affected dogs may also display a vari-
ety of clinical signs such as noisy and laboured breathing, regurgitation/vomiting, heat and
exercise intolerance, cyanosis, and collapse. The clinical signs are usually chronic and deterio-
rate with time if the lesions are left untreated [1–6].
Welfare concerns about brachycephalic breeds have been raised recently due to the soaring
popularity and the assumed high prevalence of BOAS. The FB, for example, has within the
past-ten years gone from the 76th (324 FB registered, 2005) to the 4th (9670 FB registered,
2014) most popular breed registered in the UK with, in addition, a large number of unregis-
tered dogs being imported [7]. The severity of the respiratory compromise associated with
BOAS is reported to be increasing [5]. However the syndrome lacks a single distinguishing fea-
ture and is usually identified by the presence of a combination of clinical signs and laboratory
manifestations. The only well described clinical grading system for BOAS is based on history as
reported by dog owners in terms of the type and frequency of respiratory signs [4]. Unfortu-
nately, low disease recognition by owners makes it likely that BOAS in brachycephalic dogs is
significantly under-diagnosed [8]. A lack of objective data on respiratory function makes it dif-
ficult to monitor the presence or progress of the disease. To minimise the welfare impact on
the increased population of affected brachycephalic dogs, and to inform therapeutic decisions,
further characterisation of respiratory parameters in the disease and a specific screening test
for BOAS are required.
Non-invasive respiratory measurements previously used in dogs include a face mask and
pneumotachograph, used to develop tidal breathing flow volume loops (TBFVL) for assess-
ment of airway obstruction [9–12]. However, practical issues make it difficult to establish a
‘gold standard’ diagnostic test for BOAS in client-owned dogs. Designing a face mask that
forms an airtight seal on brachycephalic dogs is technically difficult, leading to increased dead
space and leakage that may cause underestimation of flow rates. Having a mask over the face
may also result in stress in brachycephalic dogs, changing the respiratory waveforms [9].
Head-out whole body plethysmography (HOP) and spirometry encounter the same problem
as the use of a face mask is required [13–16].
Whole-body barometric plethysmography (WBBP) is a non-invasive and objective tech-
nique to measure respiratory function while the animal is fully conscious and minimally
restrained [17–23]. The animal rests in the WBBP chamber and respiration causes barometric
pressure oscillations proportional to tidal volume. Pumped bias airflow maintains carbon diox-
ide levels, temperature and humidity at normal ranges enabling long-term measurements [24].
In previous studies using WBBP to assess respiratory function in 11 brachycephalic dogs [17]
and other canine breeds [19,21,22,25], sedation has typically been used to reduce panting and
movement making WBBP easier to interpret. However, a significant effect of sedation on respi-
ratory parameters in experimental beagles was reported and the muscle relaxant properties of
sedation could exacerbate any existing upper airway obstruction [19,26–28].
A modified WBBP protocol using unsedated dogs has been tested by the authors on over
620 untrained dogs among 41 breeds. Stress behaviours were not observed in the large majority
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(see also Hirt et al., 2007) [29]. This non-invasive method can be used to screen brachycephalic
canine populations as a routine respiratory function assessment. The method was therefore
adopted for the present study.
The aims of the study were to (1) characterize respiratory cycles using WBBP in non-
brachycephalic control dogs and FB with a range of respiratory compromise; (2) construct and
validate a model and a score system (BOAS Index) to discriminate the respiratory cycles of FB
with moderate/severe BOAS from those without significant clinical signs. It is proposed that a
WBBP test followed by computational analysis of respiratory cycles would be a useful tool in




‘Patient FB’ (i.e. FB that were referred for BOAS consultation at the Queen’s Veterinary School
Hospital, QVSH) and ‘study FB’ (i.e. FB volunteered by UK owners and breeders) were
recruited to the study between September 2011 and November 2014. Non-brachycephalic dogs
referred to QVSH for other than respiratory diseases, and non-brachycephalic staff owned
dogs, were included in this study as controls. The Department of Veterinary Medicine, Univer-
sity of Cambridge approved this study under informed ethical consents, CR62 and CR63. All
dog owners gave informed consent for the inclusion of their animals in the study. A detailed
history of the dog was taken from the owners, including type, severity, and frequency of respi-
ratory signs, while awake at rest, while sleep, and during physical exercise (S1 File). Body
weight (BW), body condition score (BCS, a standard assessment of whether animals are under-
weight or overweight by use of a nine-point scale), gender and age were noted. Dogs that had
been diagnosed with overt lower airway disease and/or were younger than one year old were
excluded from the study.
Functional Grading System for BOAS
A functional grading system of BOAS severity was designed for an initial comparison of respi-
ratory performance amongst dogs, and for further use in training the computational classifier
onWBBP data (Table 1). The functional grading system was based on clinical evaluation
before and after a 3-minute exercise tolerance test (ETT) with trotting speed of approximately
4–5 miles per hour performed by the study investigators. Each dog was assigned with a BOAS
function grade: Grade III as severe BOAS, where the owners are advised that the dogs require
immediate surgical intervention; Grade II as moderate BOAS, in which the dogs have clinically
relevant disease, requiring medical attention (i.e. management and/or surgical intervention);
Grade I as mild BOAS, in which the dogs show mild stertorous noise but exercise tolerance is
unaffected. Grade 0 dogs show no signs of BOAS and are considered BOAS free.
Data Collection: Non-invasive Respiratory Function Test Using WBBP
WBBP was performed by placing the dog into a transparent Perspex chamber (Model PLY-360
for dogs, EMMS) with balanced airflow (20L/min) and an inner volume of 280.0 L (100 cm x
40 cm x 70 cm) (Fig 1). A pressure differential transducer (TPF-100, EMMS) was attached to
the top of the chamber. Transduced signals were amplified using a strain gauge amplifier and
digitized using commercial software (ESS-102 EMMS Data Acquisition, eDacq, for Microsoft
Windows XP). Dynamic calibration of the box pressure signal was performed before each test
by injecting 50 mL of room air via a syringe into the chamber and integrating under the
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resultant flow curve. The chamber used the exterior room air as a reference. After the dog was
acclimatised to the testing environment for 5–10 minutes, measurements were recorded for 20
minutes. Subject behaviour was monitored using a digital camera. Any dog that did not tolerate
the test (i.e. showed signs of anxiety) for 5 minutes during the first recording was removed, and
given a second attempt when calm. Dogs that were not tolerant after two acclimatising sessions
were excluded from this study.
An illustration of a WBBP flow waveform for a single breath cycle is shown in Fig 2. Selected
respiratory parameters: tidal volume (TV), inspiratory time (Ti), expiratory time (Te), peak
inspiratory flow rate (PIF), peak expiratory flow rate (PEF), respiratory rate (RR), and minute
ventilation (MV) were used to characterise the WBBP flow waveform. The data processing pro-
cedures involved in quantifying a plethysmographic flow waveform comprised: automatically
marking the start and finish of each breath cycle using eDacq software; the extraction of trace
features associated with body movement or vocalization according to the video recording; and
manual exclusion of incorrectly computer-detected respiratory cycles. Breath cycles used in the
study were those in which the difference between inspiratory volume and expiratory volume
were balanced within 20% and the dog was relaxed and still, and was not panting. The first 20
such breath cycles during wakefulness in each dog’s record were used for subsequent analysis.
Statistical Analysis, Classifier Design, and the Derivation of a BOAS
Index
The respiratory functional consequences of a Grade I assessment for the dog are very minor, so
for binary comparisons between functionally BOAS—and BOAS + FB, ‘Grade 0 and Grade I
FB’ were compared with ‘Grade II and Grade III FB’. In the remainder of the article Grade0/I
Table 1. Functional grading system of brachycephalic obstructive airway syndrome (BOAS) based on respiratory signs before and after an exer-
cise tolerance test (ETT).
Respiratory noise a Inspiratory effortb Dyspnoea/ Cyanosis/ Syncopec
Grade 0 Pre-ETT Not audible Not present Not present
Post-ETT Not audible Not present Not present
Grade I Pre-ETT Not audible or mild Not present Not present
Post-ETT Mild Not present to mild Not present
Grade II Pre-ETT Mild to moderate Mild to moderate Not present
Post-ETT Moderate to severe Moderate to severe Mild dyspnoea; cyanosis or syncope not present
Grade III Pre-ETT Moderate to severe Moderate to severe Moderate to severe dyspnoea; may or may not present cyanosis. Inability to exercise.
Post-ETT Severe Severe Severe dyspnoea; may or may not present cyanosis or syncope.
The clinical grading was based on respiratory signs before (pre-ETT) and immediately after the exercise tolerance test (post-ETT) as described in the
methods section.
a Respiratory noise was diagnosed by pharyngolaryngeal auscultation. Mild: only audible under auscultation; moderate: intermittent audible noise that can
be heard without stethoscope; severe: constant audible noise that can be heard without stethoscope.
b An abnormal respiratory cycle characterized by evidence of increased effort to inhale the air in with the use of diaphragm and/or accessory muscles of
respiration and/or nasal ﬂaring with an increase in breathing rate. Mild: regular breathing patterns with minimal use of diaphragm; moderate: evidence of
use of diaphragm and accessary muscles of respiration; severe: marked movement of diaphragm and accessary muscles of respiration.
c Dogs that have had episodes of syncope and /or cyanosis as documented by owner’s report are classiﬁed into Grade III without ETT. Mild dyspnoea:
presents sign of discomfort; Moderate dyspnoea: irregular breathing, signs of discomfort; severe dyspnoea: irregular breathing with signs of breathing
discomfort and difﬁculty in breathing.
doi:10.1371/journal.pone.0130741.t001
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will be referred to as BOAS- and Grade II/III as BOAS+. BOAS- FB were compared with BOAS
+ FB on gender using Pearson’s chi-square tests; on age and BCS using independent t-test. Sta-
tistical tests were conducted using SPSS (IBM, version 22.0 for Mac). A p value<0.05 was con-
sidered statistically significant.
After a pilot investigation PEF/PIF, Te/Ti, andMV/BWwere used in the proposed classifier.
These parameters were previously reported as indicators of upper airway functionality using
TBFVL and also showed significant differences in the pilot study [9,10]. Initial overview of the
distribution of these parameters suggested that respiratory cycles of functional BOAS+ FB show
higher variation between dogs and within dog than did those of BOAS- FB. Therefore the means
and standard deviations of each of the parameters were derived from 20 representative breaths
selected for each dog. Normality of the data within groups was tested by Kolmogorov-Smironov
Fig 1. The chamber used for whole-body barometric plethysmography (WBBP) with a French bulldog undergoing the test. A pole of the chamber
pressure differential transducer is opened to the top of the chamber (C); two inlets (A and B) are connected to the front and back of the chamber in order to
ventilate with a bias flow of room air (20 L/minute); an audio sensor is located on the top of the chamber (D); together with pneumotachograph screens (E).
doi:10.1371/journal.pone.0130741.g001
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(K-S) test; Homogeneity of variance was tested by Lavene’s test. Independent t-tests were used
to compare the means between groups: (1) non-brachycephalic controls versus Grade 0 FB con-
trols; (2) BOAS- FB versus BOAS+ FB.
A summarised flow-chart for classifier design is shown in Fig 3. The FB subjects were
divided into 2 groups: a training group and a test group of 20 more recently recruited dogs.
The dogs in the training group were tagged with the appropriate labels (i.e. the functional grad-
ing results) and used to develop and train the classification algorithms. Quadratic discriminant
analysis (QDA) was used to examine these six variables to determine which group the record
for each dog fell into. QDA generates a quadratic surface in the feature space to separate two or
more classes. In a probabilistic setting where four-class QDA corresponds to minimum-error-
probability classification of samples from four multivariate Gaussian sub-populations, this
parameter reflects the relative prior probabilities of the four classes.
A predictive index was constructed as a simple score system by modelling the posterior
probabilities generated from QDA (i.e. px (%) = posterior probability of being classified into
functional ‘Grade X’, p0 + pI + pII + pIII = 100%) with weights for the relative disease severity
added for each posterior probability. The interval of disease severity was assumed to be equal.
The score range is from 0 (the centre of the Grade 0 population) to 100% (the centre of the
Grade III population):
BOAS Index ð%Þ ¼ 0  p0 þ 1=3  pI þ 2=3  pII þ 1  pIII
Binary classiﬁcation was used to discriminate between BOAS- and BOAS+ FB. The diagnostic
value of the BOAS index was assessed by calculating the area under the receiver operating char-
acteristic (ROC) curve. The performance metrics were computed over 2,000 bootstrap samples
of the whole dataset to generate the conﬁdence intervals to delineate the expected range of clas-
siﬁer performance and a cross-validation test was applied. Diagnostic accuracy was calculated
as sensitivity, speciﬁcity, and positive and negative predictive values.
The cut off value selected from the ROC curve was that which best identified significant
BOAS where the sensitivity and specificity are approximately equal. The predictive accuracy of
the model was then tested in the test group. Functional grades of dogs in the test group were
initially withheld to permit blinded application of our algorithms to these records, and then
revealed to allow final evaluation of performance. Computations for data processing, feature
extraction, QDA, bootstrap resampling, and ROC construction were implemented using the
Fig 2. WBBP flow waveform illustration for a single respiratory cycle. The flow cycle starts from
inspiration (below the zero line of flow rate) then expiration (above the zero line of the flow rate).
doi:10.1371/journal.pone.0130741.g002
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packages “MASS”, “verification”, and “caret” available in the R Project (software platform R
3.1.1. for Mac OS X GUI, http://www.R-project.org).
Results
Subjects Characteristics
Eight-nine FB (19/89 ‘patient FB’ and 70/89 ‘study FB’) and 20 non-brachycephalic controls
were included in the study. Subject characteristics are given in Table 2. The prevalence of
BOAS+ within the total sample group (n = 89) in this study was calculated as 0.54 (95% CI:
0.43–0.65); prevalence of 0.43 (95% CI: 0.31–0.55) was calculated for the study FB (n = 70). 18/
30 (60%) of the owners of the BOAS+ study FB reported their dogs never or rarely produced
loud respiratory noise and/or breathing difficulty during exercise. There was a significant asso-
ciation between gender and BOAS status, male FB having a prevalence risk ratio of BOAS
+ 1.90 times higher than female FB (95% CI = 1.28 to 2.82, p<0.01). BCS showed a small
increase with grade in functional tests (mean BCS = 5.0 in Grade 0, 5.29 in Grade I, 5.72 in
Grade II and 6.00 in Grade III). BOAS- FB had a significantly lower BCS than BOAS+ FB
(mean BCS = 5.23 and 5.79, respectively, p<0.01). Age was not significantly associated with
BOAS status.
Fig 3. A flowchart of the study design.WBBP = whole body barometric plethysmography; BOAS = brachycephalic obstructive airway syndrome;
QDA = quadratic discriminant analysis; SD = standard deviation; Te/Ti = expiratory time/ inspiratory time; PEF/PIF = ratio of peak expiratory flow to peak
inspiratory flow; MV/BW =minute volume / body weight.
doi:10.1371/journal.pone.0130741.g003
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Respiratory patterns in FB and non-brachycephalic controls
Fig 4 shows the representative constant real-time flow traces with resting RR of non-brachyce-
phalic controls, BOAS- FB and BOAS+ FB. The BOAS+ FB show higher variability in the flow
trace characteristics compared to the other two groups, with three main types of flow trace
being observed. Type 1 results from restrictive airflow both during inspiration and expiration
(flat and square shape, Fig 4C); Type 2 presents with restrictive flow during inspiration but a
high peak flow rate during the early expiratory phase followed by an immediate levelling off of
flow rate (Fig 4D). Type 3 presents with considerable fluctuating inspiratory airway flow but
no significant high peaks during expiration (Fig 4E). Some BOAS+ FB display a mixture of the
three types of trace. Noise/unstable flow (i.e. low amplitude, high frequency variation in flow
rates) is seen overlying the respiratory cycles of most BOAS+ FB.
Single breath respiratory cycles from all participating dogs were plotted in Fig 5 against the
selected features of Te/Ti, PEF/PIF, and MV/BW. The BOAS+ FB show higher variability
between dogs and within dogs when compared to BOAS- FB and non-brachycephalic controls
(Fig 5A). Breaths plots of the two extreme FB groups (i.e. Grade III and Grade 0 FB) are shown
in Fig 5B. Fig 5C compares Grade 0 FB controls and non-brachycephalic controls. The Grade 0
FB controls show a partial overlap in distribution of the breath plots with non-brachycephalic
control dogs.
Nonetheless, there are measureable differences in average breathing cycles between these
Grade 0 FB controls and non-brachycephalic controls; and between BOAS- FB and BOAS+ FB
(Table 3). The Grade 0 FB controls have a significantly lower mean of Te/Ti and higher mean
of PEF/PIF than non-brachycephalic controls. A slight trend to reduced MV/BW in the Grade
0 FB controls compared with non-brachycephalic controls was not significant. Variations (i.e.
standard deviations) in the selected parameters were not significantly different between the
Grade 0 FB controls and non-brachycephalic controls. BOAS+ FB showed on average a 33%
elevation in PEF/PIF (p<0.001) and a 12% elevated MV/BW (p<0.05) when compared to
BOAS- FB. For both parameters, standard deviations were also elevated significantly. Variation




Dog number 89 20
Female (%) 58.43 65.0
Age (years) 2.5 (1–11) 3.13 (1–12)
Body weight
(kg)
11.5 (9–17) 13.55 (6.7–27)
BCS (1–9) 6 (4–8) N/A
Functional
grade a
0 (n = 9, 10.11%); I (n = 32, 35.96%); II (n = 35,
39.33%); III (n = 13, 14.61%);
0 (n = 20)
Subject type Patient dogs (n = 19); Study dogs (n = 70) Study dogs (n = 20)
Data are presented as median (minimum-maximum). BOAS refers to Brachycephalic Obstructive Airway
Syndrome; BCS, body condition score.
a Functional grades, refer to Table 1.
b Breeds: English springer spaniel (n = 2), Border collie (n = 1), Jack Russell terrier (n = 1), Labrador
retriever (n = 3), American bullterrier (n = 1), Beagles (n = 6), Dachshund (n = 1), Cairn terrier (n = 1), West
Highland white terrier (n = 1), cross breeds (n = 3).
doi:10.1371/journal.pone.0130741.t002
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Fig 4. Representative WBBP flow waveforms for several study dogs. (A) non-brachycephalic control dog; (B) BOAS- French bulldog; (C) BOAS+ French
bulldog, respiratory cycle Type 1; (D) BOAS+ French bulldog, Type 2; (E) BOAS+ French bulldog, Type 3.
doi:10.1371/journal.pone.0130741.g004
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of Te/Ti was significantly higher (p<0.01) in BOAS+ FB but mean Te/Ti was not significantly
different from BOAS- FB.
QDA Classifier performance and Evaluation of BOAS Index
The FB subjects were divided into 2 datasets: a training dataset of 69 FB, and a test dataset of
20 FB. The QDA results show the classification accuracy for four-group (i.e. Functional Grade
Fig 5. Breaths plotted against three selected respiratory parameters. FB = French bulldogs; PEF/
PIF = peak expiratory flow rate/ peak inspiratory flow rate; MV/BW =minute ventilation/ body weight, ml/kg;
Te/Ti = expiratory time/ inspiratory time. 20 representative breaths per dog.
doi:10.1371/journal.pone.0130741.g005
Table 3. Respiratory parameters measured by whole-body barometric plethysmography (WBBP).
Comparison 1 Comparison 2
Non-brachycephalic controlsa
(n = 20)




BOAS + French bulldogsb
(n = 48)
RR_m 20.85 ± 2.22 22.55 ± 5.87 * 23.13 ± 2.89 22.55 ± 5.04
RR_sd 5.48 ± 1.22 2.84 ± 1.46 2.89 ±1.19 3.27 ± 1.38
TV/BW_m 8.77±1.98 12.10±3.25** 9.96±2.57 11.05±3.38
TV/BW_sd 1.30±0.35 1.66±0.49 1.64±0.62 2.16±0.98 τ τ
MV/BW_m 236.83 ± 32.35 213.70 ± 27.78 215.42 ± 24.53 241.46 ± 76.31 τ
MV/
BW_sd
28.93 ± 8.43 25.07 ± 10.79 26.27 ± 8.88 40.31 ± 19.01 τ τ τ
Te/Ti_m 1.36 ± 0.16 0.962 ± 0.18 *** 1.06 ± 0.27 π 1.07 ± 0.39
Te/Ti_sd 0.20 ± 0.06 0.174 ± 0.06 0.20 ± 0.07 0.29 ± 0.15 τ τ, π
PEF/
PIF_m
0.84 ± 0.08 1.04 ± 0.14 *** 0.99 ± 0.15 1.32 ± 0.42 τ τ τ
PEF/
PIF_sd
0.12 ± 0.04 0.142 ± 0.04 0.17 ± 0.06 0.32 ± 0.18 τ τ τ, π
Means (m) and standard deviations of the means (sd) of RR, Te/Ti, PEF/PIF, and MV/BW were calculated for 20 breaths collected from each dog.
RR = respiratory rate (breath per minute); Te/Ti = expiratory time (s) /inspiratory time(s); PEF/PIF = peak expiratory ﬂow rate (ml/s)/ peak inspiratory ﬂow
rate (ml/s); MV/BW = minute volume (ml)/ body weight(kg); m = mean of the parameter calculated from the 20 breaths of each dog; sd = standard
deviation of the parameter calculated from the 20 breaths of each dog.
a Breeds: English springer spaniel (n = 2), Border collie (n = 1), Jack Russell terrier (n = 1), Labrador retriever (n = 3), American bullterrier (n = 1), Beagles
(n = 6), Dachshund (n = 1), Cairn terrier (n = 1), West Highland white terrier (n = 1), cross breeds (n = 3).
b BOAS- FB = Grade 0/I FB; BOAS+ FB = Grade II/III FB. Functional grades, refer to Table 1.
π The Kolmogorov-Smironov test was signiﬁcant (i.e. data were not normal distributed); p<0.05.
* Signiﬁcantly different from the non-brachycephalic control group, *p<0.05; **p<0.01; ***p<0.001.
τ Signiﬁcantly different from the BOAS- French bulldogs; τ p<0.05; τ τ p<0.01; τ τ τ p<0.001.
doi:10.1371/journal.pone.0130741.t003
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0, I, II, and III) discrimination was 84.06%; for binary discrimination it was 94.2% (i.e. BOAS-
versus BOAS+). No Grade 0 FB were misclassified into BOAS+ group; none of the Grade III
FB were misclassified into BOAS- (S2 File).
A BOAS Index was calculated for each member of the FB training group (Fig 6). The diag-
nostic value of this index was assessed in the training group by compiling a ROC curve, show-
ing an area under the curve of 0.99 (95% CI: 0.97–1.0), which indicates a high accuracy of the
test (Fig 7). The cut-off value (BOAS index = 0.46) was chosen to yield approximately equal
sensitivity (0.97, 95%CI: 0.85–1.0) and specificity (0.93, 95%CI: 0.76–0.99). Classification accu-
racy was 0.96. Positive predictive value and negative predictive value were 0.95 and 0.97,
respectively. When the model was applied to the test dataset, 8 out of 9 BOAS+ FB and all
BOAS- FB (n = 11) were correctly identified (classification accuracy = 0.95). Table 4 shows the
optimized classification performance for both training and test datasets.
Discussion
In the present study, a novel approach to quantitative WBBP flow trace analysis was developed.
The WBBP respiratory cycles of resting FB with known exercise ability were compared with
non-brachycephalic controls as well as with each other. A BOAS Index was proposed based on
the classifier for the purpose of disease screening.
The FB is one of the breeds most predisposed to BOAS. However, a proportion of FB who
are exposed to the risk of having BOAS (i.e. extreme brachycephalic skull dimensions) do not
develop respiratory signs that are clinically concerning. In the present study a large sample of
FB subjects were from the pet and show dog population. Only about 10% of FB were found to
be Grade 0, with most dogs showing at least some degree of airway restriction. But functionally
both Grade 0 FB and Grade I FB, comprising nearly half of FB in the study, were defined as
BOAS-. The remaining FB were considered functionally BOAS+. These dogs show exercise
intolerance or even life-threatening clinical signs. The low recognition of clinical signs by the
pet owners emphasizes the need for an objective screening test. 60% of owners of affected study
FB were not able to recognize the BOAS clinical signs, which can cause a delay in treatment
and further deterioration of the disease.
The higher prevalence of the condition in males confirms the suggestion in a number of
studies of BOAS+ dogs in which males outnumber females (observed ratios of male to female
Fig 6. Classification performance of the BOAS Index. (A) Distribution of the BOAS Index for the French
bulldog training dataset; (B) Box plots of the BOAS Index for the French bulldog training dataset according to
functional grade. Boxes present lines at median, upper and lower quartiles; between whiskers = 95%
confidence interval; circles = outliers within the inner fence; stars = outliers within the outer fence.
doi:10.1371/journal.pone.0130741.g006
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in other studies: 1.7–4.45) [4,30–32]. It has been suggested that obesity may play a role in the
severity of BOAS [5], and it is well known to play a role in sleep apnoea in human patients
[33]. Here we present direct evidence confirming a role for body condition in BOAS. Although
the mean of BCS in BOAS + dogs in this population (5.79) is only slightly over ideal weight, FB
with lower BCS are less affected by BOAS. Excessive fat tissue within the upper airway may
contribute to abnormal waveform characteristics observed in FB.
Upper airway tract dimensions in brachycephalic dogs are different from those of non-
brachycephalic dogs. Significant differences were found between the respiratory patterns of
non-brachycephalic controls and Grade 0 FB controls. The most marked differences were in
parameters considered to be indicators of upper airway restriction (i.e. lower TV/BW, lower
Te/Ti, higher PEF/PIF). However, there were substantial overlaps in respiratory characteristics
Fig 7. Receiver operating characteristic (ROC) curve of the BOAS Index for diagnosis of functional BOAS+ French bulldogs. Bootstrapping was
used to generate the associated 95% confidence intervals (area in blue) to delineate the expected range of screening performance. The black dot with
whiskers (95% confidence interval) shows the position of the BOAS Index of 0.46 suggested as a cut off point for distinguishing functionally BOAS- and
BOAS+ French bulldogs.
doi:10.1371/journal.pone.0130741.g007
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and the MV/BW was not significantly different between non-brachycephalic controls and
Grade 0 FB controls. Similar findings on Te/Ti and PEF/PIF were reported in a study using a
facemask and pneumotachograph in bulldogs and Boston Terriers [9]. In brachycephalic dogs,
in response to increased upper airway resistance, inspiratory muscles contract for a relatively
longer Ti than Te resulting in a decrease in Te/Ti [34,35]. During inspiration, negative trans-
mural pressure narrows the airway and reduces PIF; whilst during expiration positive pressure
within the airway reduces narrowing, resulting in an increase in PEF relative to PIF [36]. Air-
flow and intraluminal pressure changes cause variable flow rates during respiration as a result
of the dynamic movement of soft tissues. Therefore, the BOAS- FB were compared with BOAS
+ FB, rather than using non-brachycephalic dogs.
To the authors’ knowledge, respiratory traces have not previously been characterised within
a large sample of brachycephalic dogs of a single breed. Type 2 WBBP traces (Fig 4D) demon-
strated in this study were seen in the majority of BOAS+ FB. Comparison with a previous
study of breathing patterns recorded in a smaller group of bulldogs suggest there are some dif-
ferences between bulldogs and FB results from this study. The TBFVL types reported by Amis
and Kurpershoek (1986) are similar to the Type 1 and Type 3 traces in this study (Fig 4C and
4E, respectively). But the most common respiratory trace type in BOAS+ FB, Type 2 (Fig 4D),
was not described for bulldogs [9]. This may be because of the different airway tract dimen-
sions in these two breeds. Further study on the association between different lesion sites and
WBBP flow characteristics, and breeds variations, is on-going.
The variations in Te/Ti, PEF/PIF and MV/BW increased for BOAS+ FB, which is a reflec-
tion of chaotic breathing patterns induced by dynamic airway obstructions. The mean of MV/
BW also increased for the BOAS+ FB. But the wider spread of each parameter in BOAS+ traces
is the dominant change compared with BOAS—traces, when breaths are plotted (Fig 5A). In
previous studies looking at respiratory function in brachycephalic dogs, each respiratory
parameter has been assessed independently in dogs with BOAS [9,17]. However, univariate
analysis cannot not fully characterise the variation in flow traces. Therefore a multivariate anal-
ysis with a quadratic boundary between groups was applied to classify BOAS- FB and BOAS
+ FB. Several statistical modelling approaches for classification were tested. The QDA applica-
tion consistently performed well and required only a modest amount of training data.
Table 4. Optimized classification results using BOAS Index (cut-off point BOAS Index = 0.46) for training and test French bulldogs datasets.
Screening results
Training dataset (n = 69) Test dataset (n = 20)
BOAS- BOAS+ BOAS- BOAS+
Functional Grading a 0/I (BOAS-) 28 (TN) 2 (FP) 11 (TN) 0 (FP)
II/III (BOAS+) 1 (FN) 38 (TP) 1 (FN) 8 (TP)
Classiﬁcation Accuracy 0.96 (95%CI: 0.91–0.99) 0.95 (95%CI: 0.85–1.0)
Sensitivity 0.97 (95%CI: 0.85–1.0) 0.89 (95%CI: 0.52–0.98)
Speciﬁcity 0.93 (95%CI: 0.76–0.99) 1.0 (95%CI: 0.71–1.0)
PPV 0.95 (95%CI: 0.83–0.99) 1.0 (95%CI: 0.63–1.0)
NPV 0.97 (95%CI: 0.82–0.99) 0.92 (95%CI: 0.61–0.99)
TN = true positive; FP = false positive; FN = false negative; TP = true positive; PPV = positive predictive value; NPV = negative predictive value;
BOAS = brachycephalic obstructive airway syndrome.
a Functional grading for BOAS, see Table 1.
doi:10.1371/journal.pone.0130741.t004
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BOAS is a disease that does not have an absolute gold standard of diagnosis so that the
observation of an expert clinician has been considered the only available standard to define
the diagnosis. Subjective functional grading may have intra-observer or inter-observer varia-
tions and cause misclassification. In this study, a reference standard was constructed by com-
bining multiple test results. By specifying parameters associated with BOAS+ respiratory
signs the composite reference method is standardized and easy to use, but misclassification of
subjects is likely to remain. Expert functional grading, used as the starting point here, remains
subjective, but the WBBP trace of BOAS- FB and BOAS+ FB proved to be easily distinguish-
able. In the training dataset, there were 3/69 FB that were misclassified compared with our
functional assessment. In order to minimise the effect of individual errors on classification,
cross-validation and bootstrap resampling were used. This allowed the final performance to
be assessed statistically, thus providing bounds on classification accuracy. The BOAS Index is
an indirect scale that is based on the QDA classification results. The concept of the BOAS
Index is to give a relative disease severity of each dog. According to the external validation
using the test dataset of 20 dogs with functional grade withheld, the performance of the classi-
fication is excellent. By using the ROC curve, cut-off points can be chosen for different pur-
poses. For instance, for the purpose of breeding selection, a smaller cut-off value of BOAS
Index may be selected in order to include all true positives; whilst for the purpose of making a
surgical decision, a higher cut-off value of BOAS Index may be picked up in order to avoid
false positives.
There are potential limitations to this study. Firstly, although 3 typical types of waveforms
were observed from BOAS+ FB, we have not yet been able to correlate the types of waveforms
and lesion sites. One reason is that BOAS is a multi-lesion and progressive disease that may
lead to wide variations in respiratory performance. Another difficulty is that under the UK Vet-
erinary Surgeons Act, 1966, and for the welfare benefit of individual FB patients, we are not
able to perform either CT scans of the head or endoscopic imaging from the throat and nose
from the BOAS- study FB unless the latter had a different relevant clinical condition. There-
fore, we were not able to compare the differences in airway dimensions between the group of
BOAS- and BOAS+ FB. Secondly, although the effect of external environmental factors on
WBBP was minimized by thorough calibration before each recording, variations in factors
such as temperature and humidity on the day of testing affect the physical condition of the dog
to some extent. Despite these limitations, this preliminary study correctly classified over 96%
of FB using WBBP alone. Finally, all of the WBBP data were collected from the wakeful state
only. Some of the participating dogs fell asleep at the end of the test, but the data collected dur-
ing sleeping were not used in this study. Although none of the FB included in this study had
any history of sleep apnoea, brachycephalic dogs, particularly bulldogs, have been reported as a
naturally-occurring model of obstructive sleep apnoea [37]. Further study on the WBBP traces
in BOAS-affected dogs versus non-affected brachycephalic dogs while sleeping is on-going.
Conclusions
The performance of the QDA classifier for the selected features is highly discriminating, allow-
ing accurate and objective assessment of BOAS status and subsequently an improvement in
breed health and clinical decision-making. The classifier in this study is able to provide an
objective disease probability for each dog at the time of testing and is able to monitor the dis-
ease progress. This study may assist in improving the welfare in FB and other brachycephalic
breeds. Due to the non-invasive nature of the technique, it may be used to monitor other respi-
ratory disease and to assess effectiveness of treatment in veterinary medicine and possibly,
paediatrics.
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